HomeCompareBAX vs WMB

BAX vs WMB: Dividend Comparison 2026

BAX yields 2.28% · WMB yields 2.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WMB wins by $18.9K in total portfolio value
10 years
BAX
BAX
● Live price
2.28%
Share price
$15.80
Annual div
$0.36
5Y div CAGR
-27%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$10.26
Full BAX calculator →
WMB
WMB
● Live price
2.79%
Share price
$72.47
Annual div
$2.03
5Y div CAGR
25.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.6K
Annual income
$4,655.53
Full WMB calculator →

Portfolio growth — BAX vs WMB

📍 WMB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAXWMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAX + WMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAX pays
WMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAX
Annual income on $10K today (after 15% tax)
$193.67/yr
After 10yr DRIP, annual income (after tax)
$8.72/yr
WMB
Annual income on $10K today (after 15% tax)
$237.51/yr
After 10yr DRIP, annual income (after tax)
$3,957.20/yr
At 15% tax rate, WMB beats the other by $3,948.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAX + WMB for your $10,000?

BAX: 50%WMB: 50%
100% WMB50/50100% BAX
Portfolio after 10yr
$30.1K
Annual income
$2,332.89/yr
Blended yield
7.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on WMB right now

BAX
Analyst Ratings
15
Buy
20
Hold
1
Sell
Consensus: Hold
Price Target
$19.75
+25.0% upside vs current
Range: $15.00 — $25.00
Altman Z
2.1
Piotroski
5/9
WMB
Analyst Ratings
26
Buy
8
Hold
Consensus: Buy
Price Target
$78.50
+8.3% upside vs current
Range: $66.00 — $89.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAX buys
0
WMB buys
0
No recent congressional trades found for BAX or WMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAXWMB
Forward yield2.28%2.79%
Annual dividend / share$0.36$2.03
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-27%25.1%
Portfolio after 10y$20.6K$39.6K
Annual income after 10y$10.26$4,655.53
Total dividends collected$602.00$16.7K
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusHoldBuy
Analyst price target$19.75$78.50

Year-by-year: BAX vs WMB ($10,000, DRIP)

YearBAX PortfolioBAX Income/yrWMB PortfolioWMB Income/yrGap
1← crossover$10,866$166.33$11,050$349.56$184.00WMB
2$11,750$123.31$12,275$451.59$525.00WMB
3$12,664$90.97$13,720$586.52$1.1KWMB
4$13,617$66.89$15,447$766.50$1.8KWMB
5$14,619$49.07$17,538$1,008.95$2.9KWMB
6$15,679$35.94$20,104$1,339.25$4.4KWMB
7$16,802$26.30$23,307$1,794.97$6.5KWMB
8$17,998$19.23$27,371$2,432.87$9.4KWMB
9$19,272$14.05$32,627$3,340.44$13.4KWMB
10$20,631$10.26$39,567$4,655.53$18.9KWMB

BAX vs WMB: Complete Analysis 2026

BAXHealthcare

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Full BAX Calculator →

WMBEnergy

The Williams Companies, Inc., together with its subsidiaries, operates as an energy infrastructure company primarily in the United States. It operates through Transmission & Gulf of Mexico, Northeast G&P, West, and Gas & NGL Marketing Services segments. The Transmission & Gulf of Mexico segment comprises Transco and Northwest natural gas pipelines; and natural gas gathering and processing, and crude oil production handling and transportation assets in the Gulf Coast region, as well as various petrochemical and feedstock pipelines. The Northeast G&P segment engages in the midstream gathering, processing, and fractionation activities in the Marcellus Shale region primarily in Pennsylvania and New York, and the Utica Shale region of eastern Ohio. The West segment comprises gas gathering, processing, and treating operations in the Rocky Mountain region of Colorado and Wyoming, the Barnett Shale region of north-central Texas, the Eagle Ford Shale region of South Texas, the Haynesville Shale region of northwest Louisiana, and the Mid-Continent region, which includes the Anadarko, Arkoma, and Permian basins; and operates natural gas liquid (NGL) fractionation and storage facilities in central Kansas near Conway. The Gas & NGL Marketing Services segment provides wholesale marketing, trading, storage, and transportation of natural gas for natural gas utilities, municipalities, power generators, and producers; risk and asset management; and NGL marketing services. The company owns and operates 30,000 miles of pipelines, 29 processing facilities, 7 fractionation facilities, and approximately 23 million barrels of NGL storage capacity. The Williams Companies, Inc. was founded in 1908 and is headquartered in Tulsa, Oklahoma.

Full WMB Calculator →
📬

Get this BAX vs WMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAX vs SCHDBAX vs JEPIBAX vs OBAX vs KOBAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.